Post‐marketing studies of pharmaceutical opioid abuse‐deterrent formulations: a framework for research design and reporting.

Background and aims: Opioid formulations with properties to deter abuse (abuse‐deterrent formulations; ADFs) have been developed as one response to the prescription opioid 'epidemic'. As for all medicines, ADFs undergo evaluation of safety and efficacy prior to registration for marketing. However, r...

Full description

Bibliographic Details

Published in:	Addiction Vol. 114; no. 3; pp. 389 - 400
Main Authors:	Peacock, Amy, Larance, Briony, Bruno, Raimondo, Pearson, Sallie‐Anne, Buckley, Nicholas A., Farrell, Michael, Degenhardt, Louisa
Format:	research tables/charts Journal Article
Published:	Wiley-Blackwell Mar2019
Online Access:	View this record in EBSCOhost